Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

06 Nov, EOD - Indian

SENSEX 80378.13 (1.13)

Nifty 50 24484.05 (1.12)

Nifty Bank 52317.4 (0.21)

Nifty IT 42039.5 (3.99)

Nifty Midcap 100 57355.8 (2.21)

Nifty Next 50 71389.8 (2.28)

Nifty Pharma 22920.35 (1.14)

Nifty Smallcap 100 18906.1 (2.18)

06 Nov, EOD - Global

NIKKEI 225 39480.67 (2.61)

HANG SENG 20538.38 (-2.23)

S&P 5926.08 (2.39)

Cancel

BSE Code : 532321 | NSE Symbol : ZYDUSLIFE | ISIN : INE010B01027 | Industry : Pharmaceuticals |

(31-Oct-24 11:58) Zydus Lifesciences to table results
(23-Oct-24 14:50) Zydus Life rises on in-principle approval from WHO for typhoid vaccine
(18-Oct-24 12:47) Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab
(18-Oct-24 09:29) Zydus receives USFDA approval for Fludrocortisone Acetate Tablets
(15-Oct-24 10:08) Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease
(10-Oct-24 16:08) Zydus receives USFDA approval for Paliperidone Extended-Release Tablets
(10-Oct-24 14:51) Zydus Life gets final approval from USFDA for Paliperidone drug
(01-Oct-24 12:26) Zydus' transdermal patch manufacturing facility completes USFDA inspection
(01-Oct-24 12:13) Zydus Life’s Ahmedabad facility gets EIR from USFDA
(28-Sep-24 14:42) Zydus Life gets final approval from USFDA for cancer drug

1 2 3 4 5 6 7 8 9 10

Zydus Lifesciences Ltd